Medtronic Reveal LINQ Insertable Cardiac Monitor Registry
Medtronic Reveal LINQ Insertable Cardiac Monitor Registry
The Reveal LINQ Registry will generate reliable long-term "real world" data of product performance, economic valuation, site-of-service procedural information.
The study is a prospective, non-randomized, observational, multi-center, global study. The study will characterize clinical actions initiated by Reveal LINQ arrhythmia detection and estimate procedure-related acute infection rate. Approximately 1,500 subjects will be implanted with a Reveal LINQ ICM and undergo continuous remote monitoring and be followed prospectively from insertion through 36 months.
Inclusion Criteria:
Exclusion Criteria:
San Francisco, California 94143-0138, United States
Shinagawa-Ku, 142-8555, Japan